000 | 01409 a2200409 4500 | ||
---|---|---|---|
005 | 20250513061305.0 | ||
264 | 0 | _c19930803 | |
008 | 199308s 0 0 eng d | ||
022 | _a0902-4441 | ||
024 | 7 |
_a10.1111/j.1600-0609.1993.tb00163.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTiirikainen, M I | |
245 | 0 | 0 |
_aClinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry. _h[electronic resource] |
260 |
_bEuropean journal of haematology _cMay 1993 |
||
300 |
_a279-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aLeukemia _xmetabolism |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aElonen, E | |
700 | 1 | _aRuutu, T | |
700 | 1 | _aJansson, S E | |
700 | 1 | _aKrusius, T | |
773 | 0 |
_tEuropean journal of haematology _gvol. 50 _gno. 5 _gp. 279-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1993.tb00163.x _zAvailable from publisher's website |
999 |
_c8099862 _d8099862 |